27.77
전일 마감가:
$27.89
열려 있는:
$28.05
하루 거래량:
3.77M
Relative Volume:
0.94
시가총액:
$14.25B
수익:
$11.89B
순이익/손실:
$-560.00M
주가수익비율:
-25.25
EPS:
-1.1
순현금흐름:
$191.00M
1주 성능:
-3.24%
1개월 성능:
-6.81%
6개월 성능:
-10.36%
1년 성능:
-22.17%
박스터 인터내셔널 Stock (BAX) Company Profile
명칭
Baxter International Inc
전화
(224) 948-2000
주소
ONE BAXTER PARKWAY, DEERFIELD, IL
BAX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
BAX
Baxter International Inc
|
27.77 | 14.73B | 11.89B | -560.00M | 191.00M | -1.10 |
![]()
ISRG
Intuitive Surgical Inc
|
518.62 | 183.53B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
178.85 | 50.43B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
87.35 | 43.27B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
257.92 | 37.30B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
210.89 | 16.32B | 2.90B | 467.20M | 306.90M | 6.37 |
박스터 인터내셔널 Stock (BAX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-02-26 | 재개 | Goldman | Buy |
2025-02-24 | 업그레이드 | Argus | Hold → Buy |
2025-02-20 | 재개 | Barclays | Overweight |
2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
2024-05-30 | 개시 | Goldman | Neutral |
2024-05-10 | 다운그레이드 | TD Cowen | Buy → Hold |
2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
2023-03-29 | 개시 | UBS | Neutral |
2023-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2023-01-05 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2023-01-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
2022-12-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2022-12-15 | 다운그레이드 | Deutsche Bank | Buy → Hold |
2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
2022-10-18 | 개시 | Barclays | Overweight |
2022-10-12 | 개시 | Jefferies | Hold |
2022-06-24 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2022-04-04 | 다운그레이드 | Goldman | Neutral → Sell |
2022-03-02 | 재개 | BofA Securities | Buy |
2022-02-18 | 재확인 | KeyBanc Capital Markets | Overweight |
2022-02-18 | 재확인 | Morgan Stanley | Overweight |
2022-02-18 | 재확인 | Raymond James | Outperform |
2022-02-18 | 재확인 | Stifel | Buy |
2022-02-18 | 재확인 | UBS | Neutral |
2022-02-18 | 재확인 | Wells Fargo | Overweight |
2022-02-11 | 개시 | Goldman | Neutral |
2022-01-07 | 재개 | Citigroup | Buy |
2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2021-09-13 | 업그레이드 | Cowen | Market Perform → Outperform |
2021-09-03 | 업그레이드 | Barclays | Equal Weight → Overweight |
2021-05-25 | 개시 | Barclays | Equal Weight |
2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2021-01-06 | 다운그레이드 | UBS | Buy → Neutral |
2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
2020-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
2020-09-04 | 다운그레이드 | Argus | Buy → Hold |
2020-06-24 | 개시 | Oppenheimer | Outperform |
2020-03-19 | 업그레이드 | Stifel | Hold → Buy |
2020-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-03-05 | 개시 | Citigroup | Neutral |
2020-02-13 | 개시 | Goldman | Buy |
2020-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
2019-12-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2019-06-26 | 개시 | KeyBanc Capital Markets | Sector Weight |
2019-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2019-01-02 | 업그레이드 | Citigroup | Neutral → Buy |
2019-01-02 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
2018-11-02 | 업그레이드 | Argus | Hold → Buy |
2018-10-16 | 개시 | Barclays | Underweight |
2018-05-17 | 재개 | Piper Jaffray | Overweight |
2018-02-06 | 재확인 | Citigroup | Neutral |
2018-01-03 | 개시 | Evercore ISI | Outperform |
2018-01-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
모두보기
박스터 인터내셔널 주식(BAX)의 최신 뉴스
Cooke & Bieler LP Reduces Position in Baxter International Inc. (NYSE:BAX) - MarketBeat
What analysts say about Baxter International Inc. stockFree High-Return Strategy Alerts - Autocar Professional
Is Baxter International Inc. a good long term investmentBreakthrough profits - Autocar Professional
Baxter International Inc. Stock Analysis and ForecastSuperior portfolio returns - Autocar Professional
What drives Baxter International Inc. stock priceExceptional risk-adjusted gains - Autocar Professional
Baxter International Q2 2025 Financial Results Conference Call - AInvest
New York State Common Retirement Fund Has $21.34 Million Stock Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Invests $8.43 Million in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter: Margin-Focused Model Faces Growth Constraints (NYSE:BAX) - Seeking Alpha
How Renae Kezar will Lead Sustainability at Baxter - Healthcare Digital
Healthcare: Who is Renae Kezar, Baxter’s New CSO? - Sustainability Magazine
Further weakness as Baxter International (NYSE:BAX) drops 6.1% this week, taking five-year losses to 65% - simplywall.st
Cullen Frost Bankers Inc. Purchases 31,819 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors - Business Wire
Baxter International Inc. (NYSE:BAX) to Issue Quarterly Dividend of $0.17 - MarketBeat
Baxter International's Upcoming Q2 2025 Earnings AnnouncementNews and Statistics - IndexBox
What To Expect From Baxter International's Q2 2025 Earnings Report - Barchart.com
Baxter appoints Andrew Hider as CEO - MSN
Baxter Intl: Analyst Sentiments and 12-Month Price Targets - AInvest
Assessing Baxter Intl: Insights From 5 Financial Analysts - Benzinga
Baxter International (NYSE:BAX) Price Target Lowered to $27.00 at Morgan Stanley - MarketBeat
Morgan Stanley Trims Baxter International Price Target to $27 From $28, Maintains Underweight Rating - MarketScreener
Baxter price target lowered to $27 from $28 at Morgan Stanley - TipRanks
Baxter International's Dividend Policy: A Steady Beacon in a Shifting Medtech Landscape - AInvest
Baxter International Keeps Quarterly Dividend at $0.17 a Share, Payable Oct. 1 to Shareholders of Record Aug. 29 - MarketScreener
Baxter Declares Quarterly Dividend - Business Wire
Citigroup Cuts Baxter International (NYSE:BAX) Price Target to $32.00 - MarketBeat
Medical Equipment Maker Baxter International Names New CEO - MSN
UBS Affirms Neutral Rating on Baxter International (BAX) - MSN
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
ARGA Investment Management LP Grows Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Evercore ISI Cuts Baxter International (NYSE:BAX) Price Target to $42.00 - MarketBeat
Analysts Set Baxter International Inc. (NYSE:BAX) PT at $36.14 - MarketBeat
Citigroup Adjusts Baxter International's Price Target to $32 From $34, Keeps Neutral Rating - MarketScreener
Baxter International (BAX) Receives a Hold from Wells Fargo - The Globe and Mail
Transformed Baxter, in search of stability after changes, turns to outsider CEO - Crain's Chicago Business
Bank of New York Mellon Corp Decreases Stock Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Appoints Andrew Hider as New CEO - The Globe and Mail
Baxter International looking to bounce back - MarketScreener
Non-PVC IV Bags Market Is Booming So Rapidly 2025-2032 -Baxter - openPR.com
Baxter International Inc. stock underperforms Monday when compared to competitors - MSN
Baxter International's New Leadership: Can Andrew Hider Steer the Medtech Giant to Sustainable Growth? - AInvest
Baxter International taps Andrew Hider as CEO - Reuters
Baxter International appoints new CEO, months after former leader abruptly retired - Chicago Tribune
Baxter International drops after co names new CEO - TradingView
Baxter names Andrew Hider as next CEO - Medical Economics
Baxter names industry outsider as CEO - Modern Healthcare
Baxter turns to an automation company for its new CEO - MassDevice
ATS Corporation stock falls as CEO Hider departs for Baxter International - Investing.com
Baxter names a new CEO - Crain's Chicago Business
BofA Securities reiterates Neutral rating on Baxter International stock - Investing.com
박스터 인터내셔널 (BAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):